No Carolina / New York / Florida        Ph: 561.316.3330

Clinical-Grade AFE from Analog Devices Measures Four Vital Signs for Remote Patient Monitoring Devices

The MAX86178 Enables Synchronized Optical PPG and ECG Timing for Derived Health Metrics

What To Know

  • With three clinical-grade subsystems integrated into one IC, the MAX86178 triple system AFE replaces discrete implementations by integrating an optical PPG sub-system to measure heart rate and SpO2, a single lead ECG sub-system, as well as a biopotential and bioimpedance (BioZ) sub-system to measure respiration rate.
  • In addition, Analog Devices offers the MAX20343 buck-boost regulator and the MAX20360 power management IC as power solutions optimized for the MAX86178.

Simplify the design of wearable remote patient monitoring (RPM) devices by measuring four vital signs with one MAX86178 triple-system vital signs analog front end (AFE) from Analog Devices, Inc.

This single-chip AFE integrates three measurement systems (optical, ECG and bio-impedance) to obtain four common vital signs: electrocardiogram (ECG or EKG), heart rate (ECG or optical PPG), blood-oxygen saturation (SpO2) and respiration rate (using BioZ). The MAX86178 enables synchronized optical PPG and ECG timing for derived health metrics.

  • View the MAX86178 triple-system vital signs AFE product page, download the datasheet and order samples: https://bit.ly/MAX86178_Product
  • Download a high-resolution image: https://bit.ly/Image_MAX86178
  • Connect with engineers and ADI product experts on EngineerZone™, an online technical support community: https://ez.analog.com

Medical device designers are eager to reduce annual healthcare-related expenditures by replacing office-based health monitoring systems with smaller, lower power, wireless devices worn discreetly and continuously in the home or office. With three clinical-grade subsystems integrated into one IC, the MAX86178 triple system AFE replaces discrete implementations by integrating an optical PPG sub-system to measure heart rate and SpO2, a single lead ECG sub-system, as well as a biopotential and bioimpedance (BioZ) sub-system to measure respiration rate. It permits small vital signs devices by fitting those multiple functions into a 2.6mm x 2.8mm package.

In addition, next-generation wearable RPMs need to operate at low power to permit smaller batteries or extend battery life to allow more convenient charging requirements. To enable ultra-low power features, the MAX86178 provides each subsystem with configurable options to optimize battery life for specific use cases.

“By integrating three healthcare subsystems on one piece of silicon, Analog Devices builds on its DNA and delivers this sensor-fusion product,” said Andrew Burt, Executive Business Manager of the Industrial and Healthcare Business Unit at Maxim Integrated®, now part of Analog Devices. “This AFE is resonating with the medical community because it presents new possibilities for chronic disease management, contagious disease diagnosis and remote monitoring. The MAX86178 enables small body-worn devices that can improve healthcare delivery and lower costs by keeping people out of the hospital.”

In addition, Analog Devices offers the MAX20343 buck-boost regulator and the MAX20360 power management IC as power solutions optimized for the MAX86178.

MAX86178 Triple-System Vital Signs AFE Features and Benefits

  • Small Size: Replaces medical facility grade monitoring systems with body-worn devices
  • Simplified Design: By integrating and synchronizing three different measurement systems to measure four vital signs, it simplifies design and enables even more complicated derivative vital signs monitoring

Availability

Product

Availability

Packaging

MAX86178

Now

2.6mm x 2.8mm WLP package 

MAX86178EVKIT#

Now

N/A

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

A significant review found that a staggering 77.2% of nurses experience Work-Related Musculoskeletal Disorders within a year. This high incidence rate highlights the physical strain of nursing duties, which often include extended periods of standing, and underscores the need for effective interventions.
A clinical asset management evaluation will provide executives with valuable insights and recommendations, empowering them to enhance the organization’s long-term effectiveness, safety, and cost-efficiency. Read what our expert has to say.
Did you know clinician burnout remains a significant challenge for health systems and patients alike with over 50% of clinicians reporting feelings of burnout, largely attributed to manual documentation and administrative burdens? Read what Mr. Krakaris has to say.
When it was first announced, Apple Vision Pro was widely heralded as the savior of the VR/XR dream. Would Apple do to the spatial computing market what it did to the mobile phone market in the late noughties? What is the reality now that the device is launched – what does it mean for the business world’s adoption and effective utilization of spatial computing, and more specifically for our customers who are focused on surgical education and medical device sales and adoption? Read on.
Chuck Serrin advises since the pandemic, there has been a rise in ordering everything to the home - from vitamins to prescription drugs - and the days of venturing to a brick-and-mortar store are declining. The pharmaceutical industry is no different. It too is evolving, and pharmacy-focused businesses must make sure their systems are updated to keep up with the changing times.

By using this website you agree to accept Medical Device News Magazine Privacy Policy